Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Micronized progesterone versus GnRH agonist before hysteroscopic myomectomy for bleeding control
IRCT20110523006563N3Phase 2Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- Jan 2018
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of progesterone and triptorelin in menstrual disorders and Fibromyoma (LM) (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Hemoglobin concentration change. Started Jan 2018; status: completed.
02
Drugs
progesteronetriptorelin
03
Conditions
menstrual disordersFibromyoma (LM)
Beyond the preview
Go deeper on IRCT20110523006563N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20110523006563N3.